NSE shareholding pattern
Windlas Biotech Ltd. shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 63.31%, FIIs 2.09%, and DIIs 7.24% of Windlas Biotech Ltd. (WINDLAS). Against the Jun 2026 pattern, FII holding is up 0.05 percentage points (2.04% → 2.09%), DII down 2.6 points (9.84% → 7.24%), and promoter holding unchanged at 63.31%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns for the quarter ended 30 Sep 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Windlas Biotech Ltd. shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 63.31 | 2.09 | 7.24 | 27.36 | 2026-09-30 |
| Jun 2026 | 63.31 | 2.04 | 9.84 | 24.81 | 2026-06-30 |
| May 2026 | 63.31 | 0.99 | 10.2 | 25.5 | 2026-05-18 |
| Mar 2026 | 61.9 | 0.6 | 11.8 | 25.7 | 2026-03-31 |
| Dec 2025 | 61.99 | 0.93 | 11.44 | 25.64 | 2025-12-31 |
| Sep 2025 | 61.99 | 1.11 | 11.44 | 25.46 | 2025-09-30 |
| Jun 2025 | 62.34 | 1.44 | 11.22 | 25 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Wockhardt Limited, Zydus Lifesciences Limited, Aarti Drugs Ltd, Aarti Pharmalabs Limited, Abbott India Limited, Acutaas Chemicals Limited, Advanced Enzyme Technologies Limited, Ajanta Pharma Limited
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Windlas Biotech Ltd.?
As of the Sep 2026 shareholding pattern, promoters held 63.31% of Windlas Biotech Ltd. (WINDLAS). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in Windlas Biotech Ltd.?
Foreign institutional investors held 2.09% of Windlas Biotech Ltd. as of the Sep 2026 pattern, versus 2.04% in the Jun 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in Windlas Biotech Ltd. change in the Sep 2026 quarter?
FII holding in Windlas Biotech Ltd. was 2.04% in the Jun 2026 pattern and 2.09% in Sep 2026, a difference of 0.05 percentage points up. Promoter holding was unchanged at 63.31% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.